Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Withdrawn before enrolling · Phase 2

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to compare the effects of apomorphine, given by two different methods, to determine how best to manage dyskinesias.

Key facts

Study ID

NCT00758368

Run by

Oregon Health and Science University

People needed

0

Starts

2009-03-01

Expected to finish

2011-06-01

Last updated by the study team

2018-11-02

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• idiopathic Parkinson's Disease
• clear response to levodopa (sinemet)
• "off" at least 20% of waking day
• dyskinesias present for at least two hours of waking day
• subject or caregiver able to master use of drug delivery system (injector pen or pump)

You may not qualify if…

• physical complications that would preclude safe participation
• standing systolic BP of <80
• lack of tolerance or response to apomorphine
• drug/alcohol abuse

Where it is running

• Oregon Health and Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.